1,721,198 research outputs found
Criteria of choice in the surgical treatment of cancer of the rectum: local excision
No full textSourcerecord Id Scopus 21766-----------http://www.scopus.com/record/display.url?eid=2-s2.0-0024562693&origin=resultslist&sort=plf-f&src=s&sid=0AD5eOPNu-6AaFmiQCtIjHm%3a70&sot=aut&sdt=a&sl=37&s=AU-ID%28%22Benassai%2c+Giacomo%22+6602920646%29&relpos=17&relpos=17&searchTerm=AU-ID(\"Benassai, Giacomo\" 6602920646)--------http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=Q1i@gpCm9b3mdEmO@n6&page=6&doc=5
[Rectal prolapse: etiopathogenesis and physiopathology].
No full textSourcerecord Id Scopus 29482-----------http://www.scopus.com/record/display.url?eid=2-s2.0-0028400549&origin=resultslist&sort=plf-f&src=s&sid=0AD5eOPNu-6AaFmiQCtIjHm%3a70&sot=aut&sdt=a&sl=37&s=AU-ID%28%22Benassai%2c+Giacomo%22+6602920646%29&relpos=14&relpos=14&searchTerm=AU-ID(\"Benassai, Giacomo\" 6602920646)------------http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=Q1i@gpCm9b3mdEmO@n6&page=3&doc=3
Local treatment of minimal cancer of the rectum (preordained treatment)
No full textSourcerecord Id Scopus 21766--------http://www.scopus.com/record/display.url?eid=2-s2.0-0021836348&origin=resultslist&sort=plf-f&src=s&sid=0AD5eOPNu-6AaFmiQCtIjHm%3a70&sot=aut&sdt=a&sl=37&s=AU-ID%28%22Benassai%2c+Giacomo%22+6602920646%29&relpos=19&relpos=19&searchTerm=AU-ID(\"Benassai, Giacomo\" 6602920646)-------http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=Q1i@gpCm9b3mdEmO@n6&page=7&doc=6
Second look in colorectal surgery
No full text4 Citazioni su Scopus
PURPOSE: Follow-up should identify metachronous colonic neoplasms and precancers, suture line recurrences, and isolated liver or pulmonary metastases. For some sites of failure the surgical re-resection and multimodal approaches increase disease-free survival and quality of life. The aim of our study was to evaluate the role of the different follow-up plans and the carcinoembryonic antigen directed second-look surgery. METHODS: One hundred-sixty patients radically resected for Dukes B or C colorectal cancer were evaluated by a follow-up plan (plasma carcinoembryonic antigen every 2 months; echography every 6 months; chest x-ray every 12 months; and colonoscopy at 1 year and then every 3-5 years). RESULTS: Eighty-nine recurrences were detected (55.6 percent). In 72 recurrences plasma carcinoembryonic antigen elevation was present. Eight carcinoembryonic antigen directed second-look surgeries were performed: in four patients surgical evidence of recurrence was found (two isolated liver metastases were radically resected); two patients with no surgical evidence of recurrence developed a surrenalic isolated metastases and pelvic and hepatic recurrences; two patients had a five-year disease-free survival. In the 17 symptomatic patients with no carcinoembryonic antigen elevation diffuse disease was present, not resectable for cure. Four solitary liver metastases, one metachronous colonic neoplasm, and one suture line recurrence presented a five-year survival. CONCLUSIONS: The authors emphasize that carcinoembryonic antigen-directed second-look surgery is not acceptable for elevated costs. Intensive follow-up plans are superflous, while the monitoring of the carcinoembryonic antigen and instrumental restaging as an indicator of solitary liver metastases and mucosal lesions are very useful.-----------Sourcerecord Id Scopus 21088-------http://www.scopus.com/record/display.url?eid=2-s2.0-0028333776&origin=resultslist&sort=plf-f&src=s&sid=0AD5eOPNu-6AaFmiQCtIjHm%3a70&sot=aut&sdt=a&sl=37&s=AU-ID%28%22Benassai%2c+Giacomo%22+6602920646%29&relpos=15&relpos=15&searchTerm=AU-ID(\"Benassai, Giacomo\" 6602920646)---------------http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=Q1i@gpCm9b3mdEmO@n6&page=4&doc=3
Significance of lymph node metastases in the surgical management of pancreatic head carcinoma
No full text32 citazioni su Scopus. -----http://www.scopus.com/record/display.url?eid=2-s2.0-0032897206&origin=resultslist&sort=plf-f&src=s&sid=1BklTwBDkRxWaxt9FLi7YAz%3a70&sot=aut&sdt=a&sl=37&s=AU-ID%28%22Benassai%2c+Giacomo%22+6602920646%29&relpos=9&relpos=9&searchTerm=AU-ID(\"Benassai, Giacomo\" 6602920646) ----- 51 citazioni su Google Scholar----------Recent reports have demonstrated a reduction in the morbidity and mortality of pancreatic resections and improvement in the 5-actuarial survival for patients with resected ductal adenocarcinoma. However, the prognosis for patients with lymph node metastases remains uncertain. The purpose of this study is to determine if the presence of lymph node metastases influences the survival in patients with otherwise potentially curable pancreatic head carcinoma. Between January 1974 and December 1995, 340 patients with pancreatic carcinoma, including 238 patients with pancreatic head tumours, were evaluated and treated in our Department. Seventy-seven (32.3%) patients with pancreatic head carcinoma underwent pancreaticoduodenectomy. Ages ranged from 40 to 76 years, with a mean age of 61 years. Fifty patients were male, twenty-seven were female. The overall postoperative mortality rate was 5.2% (4 patients) and morbidity was 23.4%. Median survival following resection was 17 months (range 0 to 79). The estimated 1-, 2-, 3- and 5-year survival were 68.8%, 48.1%, 23.4% and 18.2%, respectively. There were 14 five-year survivors. Of the 77 patients, 25 (32.5%) had negative lymph nodes. The median and 5-year survival in these node-negative patients were 33 months (range 5 to 79) and 40%, respectively. Whereas the median survival and 5-year survival in 52 patients with lymph nodes metastases were 14 months (range 0 to 61) and 7.7%, respectively (P < 0.0001). There were 4 five-year survivors in the group of patients with lymph node metastases; in 2 patients was performed extensive lymph node dissection (R2) and in other 2 patients R1 procedure. In the patients with lymph node metastases undergoing RI resection (n = 39), the 1-, 2- and 5-year survival rates were 48.7%, 23.1% and 5.1%, respectively. Whereas in the patients with positive lymph nodes undergoing R2 resection (n = 14), the lr, 2- and 5-year survival rates were 92.9%, 64.3% and 14.3%, respectively (P < 0.02). As expected, tumour size and margin status in specimen proved to be two significant factors predicting survival. Pancreatoduodenectomy can be performed with low operative mortality. Lymph nodes metastases are found in 67.5% of patient undergoing resection. Pancreaticoduodenectomy offers good palliation for patients with lymph nodes metastases and encouraging long-term survival rates as well as a chance for cure in patients with negative lymph nodes and negative margins of resection
Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
No full textCitato 23 volte in letteratura Internazionale su Scopus. Citato 41 volte su GoogleScholar. ---- http://www.scopus.com/record/display.url?eid=2-s2.0-0034184368&origin=resultslist&sort=plf-f&src=s&sid=1BklTwBDkRxWaxt9FLi7YAz%3a70&sot=aut&sdt=a&sl=37&s=AU-ID%28%22Benassai%2c+Giacomo%22+6602920646%29&relpos=8&relpos=8&searchTerm=AU-ID(\"Benassai, Giacomo\" 6602920646) -----
Recent reports have demonstrated an improvement in 5-year actuarial survival of patients with resected ductal adenocarcinoma. The purpose of this study was to determine the factors favoring long-term survival after pancreaticoduodenectomy. Between 1974 and 1995, 75 patients with pancreatic head carcinoma underwent pancreaticoduodenectomy in our department. The overall postoperative mortality rate was 5.3% and morbidity was 24%. Median survival following resection was 17 months. The estimated 1-, 2- and 5-year survival rates were 68%, 46.7% and 18.7%, respectively. Five-year survival was significantly greater for node-negative versus node-positive patients (41.7% vs 7.8%, P 3 cm, and poor histologic differentiation were also independent predictors of poor survival. The most favorable subset consisted in 17 patients who had negative resection margins, negative lymph nodes, and tumor size < 3 cm. Their 5-year survival rate was 52.9%
Factors influencing Survival after resection for Ductal Adenocarcinoma of the head of the Pancreas
No full textCystadenoma of the pancreas. Our experience and a literature's review
No full textSourcerecord Id Scopus 2834
- …
